Brief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
18/09/2025 14:22
Sept 18 (Reuters) - Carisma Therapeutics Inc CARM.O: CARISMA THERAPEUTICS INC - CO & MODERNATX AMEND COLLABORATION & AND LICENSE AGREEMENT - SEC FILING CARISMA THERAPEUTICS - MODERNATX TO PAY $4 MILLION TO CO & HAS NO FURTHER OBLIGATION TO MAKE ANY FINANCIAL PAYMENTS - SEC FILING Source text: [ID:n0001104659-25-091064] Further company coverage: CARM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary